Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2019-06-28 2019-06-28
Drug Identification Number 02382539 02382539
Brand name FUROSEMIDE INJECTION SDZ FUROSEMIDE INJECTION SDZ
Common or Proper name FUROSEMIDE FUROSEMIDE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients FUROSEMIDE FUROSEMIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 2ml X 10 2ml X 10
ATC code C03CA C03CA
ATC description HIGH-CEILING DIURETICS HIGH-CEILING DIURETICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-06-03 2019-06-03
Estimated end date 2019-06-17 2019-06-17
Actual end date 2019-06-14 2019-06-14
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments